CAR T-Cell Therapy Stocks Plunge as FDA Investigates Cancer Reports Linked to Treatments
Shares of Chimeric Antigen Receptor (CAR) T cell therapy companies plummeted on November 28, 2023,...
Policy / Regulatory
China’s Pharma Distribution Market Grows Steadily in 2022, Driven by Retail Sales Surge
The Ministry of Commerce (MofCOM) has released its annual statistical review of China’s pharmaceutical distribution...
China’s NHSA Issues Guidelines to Strengthen Medical Pricing and Procurement Credit Ratings
The National Healthcare Security Administration (NHSA) has issued a notification concerning medical pricing and tendering...
China’s CDE Releases Draft Guidelines for Decentralized Trials in Rare Disease Drug Development
China’s Center for Drug Evaluation (CDE) has released draft “Technical Guidelines for the Application of...
European Commission Proposes Overhaul of Pharmaceutical Legislation
The European Commission (EC) is advancing an update to Europe’s 20-year-old pharmaceutical legislation, with the...
National Reimbursement Drug List Negotiations and Bidding Process Conclude
The on-site negotiation and bidding processes for the 2023 update to China’s National Reimbursement Drug...
Final Results of China’s Round 9 Volume-Based Procurement Tender Announced
The National Allied Procurement Office has released the finalized results and tender bid allocations for...
CDE Releases 76th Batch of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 76th batch of chemical generic reference...
China’s National Allied Procurement Office Announces VBP Tender for Medical Consumables and 3D Printing Products
The National Allied Procurement Office has released a notification outlining plans for a volume-based procurement...
China’s NMPA Officially Seeks Membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S)
The Pharmaceutical Inspection Co-operation Scheme (PIC/S) has announced that China’s National Medical Products Administration (NMPA)...
9th National Volume-Based Procurement Round Results in 70% Price Reduction for 41 Drugs
The results of the 9th round of China’s national volume-based procurement (VBP) program have been...
Guangxi HSA Expands Coverage for Assisted Reproductive Medical Services Under BMI
The Healthcare Security Administration (HSA) bureau of the Guangxi Zhuang Autonomous Region has announced a...
China’s Health Authorities Release Third List of 41 Drugs for Recommended Generic Development
The National Health Commission (NHC), National Healthcare Security Administration (NHSA), National Medical Products Administration (NMPA),...
NMPA Unveils 73rd Batch of Reference Drugs for Generic Quality Consistency
China’s National Medical Products Administration (NMPA) has released the 73rd batch of reference drugs as...
CDE Releases 75th Batch of Generic Reference Preparations with Updated Specifications
The Center for Drug Evaluation (CDE) has announced the release of the 75th batch of...
Peking University Unveils National Standardized Pain Treatment Center in China
Peking University People’s Hospital has officially unveiled the plaque for the National Standardized Pain Treatment...
NMPA Implements New Measures for Drug Manufacturing Outsourcing by MAHs
The National Medical Products Administration (NMPA) has issued a notice detailing new supervision and management...
National VBP Tender Program Invites Drugs Approved Before October 30 for Round 9
The National Allied Procurement Office has released a notification regarding Round 9 of the national...
China’s State Council Unveils Plan to Boost Patent Commercialization by 2025
China’s State Council has recently approved the “Special Action Plan for Patent Commercialization and Utilization...
NMPA Issues Guidelines for Temporary Import of Urgently Needed Medical Devices
The National Medical Products Administration (NMPA) has released new “Management Requirements for Temporary Import and...